License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association website.
Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.

Forms/Checklists/Guides

Local Coverage Determinations

Medical Review

Medicare Secondary Payer (MSP)

Print | Bookmark | Email | Font Size: + | –

Home » JB DME » News & Publications » News » 2018 » October » Topical Oxygen Request for Information Bibliography

October 4, 2018

Topical Oxygen Request for Information Bibliography

Joint DME MAC Article

In the fall of 2017, the DME MACs posted a Request for Information (RFI) regarding topical oxygen therapy for wound care that ran from September 14 through October 30, 2017 (45 days). The DME MACs supplemented the RFI by conducting their own literature search, and received literature regarding continuous diffusion of oxygen (CDO) for the treatment of chronic wounds from one manufacturer outside of the RFI.

The results from these 3 sources yielded one-hundred and fifty-two unique documents. Correspondence, Agency documents (CMS and FDA) etc. were removed from the document set, leaving one-hundred and thirty-one unique items included in the bibliography. These materials dated from 2017 back to 1967. For clinical relevance, an article publication age limit of 10 years was used (i.e., years 2007 – 2017), yielding sixty-four items for consideration. After non-clinical articles were removed, thirty-six articles remained for analysis.

Clinical Studies

Armstrong D. A Prospective, Randomized, Double Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers.; 2015.
Azimian J, Dehghan Nayeri N, Pourkhaleghi E, Ansari M. Transdermal Wound Oxygen Therapy on Pressure Ulcer Healing: A Single-Blind Multi-Center Randomized Controlled Trial. Iranian Red Crescent Medical Journal. 2015;17(11). doi:10.5812/ircmj.20211
Blackman E, Moore C, Hyatt J, Railton R, Frye C. Topical wound oxygen therapy in the treatment of severe diabetic foot ulcers: a prospective controlled study. Ostomy Wound Manage. 2010;56(6):24-31.
Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008;31(4):631-636. doi:10.2337/dc07-2196
Copeland K, Purvis AR. A Retrospective Chart Review of Chronic Wound Patients Treated with Topical Oxygen Therapy. Advances in Wound Care. 2017;6(5):143-152. doi:10.1089/wound.2017.0729
Couture, M. Does Continuous Diffusion Of Oxygen Have Potential In Chronic Diabetic Foot Ulcers? Podiatry Today. 2015;28(12).
Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Advances in skin & wound care. 2008;21(12):568–575.
Driver VR, Reyzelman A, Kawalec J, French M. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers. Ostomy/wound management. 2017;63(4):12.
Driver VR, Yao M, Kantarci A, Gu G, Park N, Hasturk H. A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus. Ostomy Wound Manage. 2013;59(11):19–26.
Edmonds M, European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the Treatment of Neuropathic Diabetic Foot Ulcers. The International Journal of Lower Extremity Wounds. 2009;8(1):11-18. doi:10.1177/1534734609331597
Gayle M Gordillo, Sashwati Roy, Savita Khanna, et.al. Topical Oxygen Therapy Induces VEGF Expression and Improves Closure of Clinically Presented Chronic Wounds. Clin Exp Pharmacol Physiol. 35(8) 2008
Mujahid MD, Iqbal MS, Riaz O, Hameed F, Hussain R. Role of Adjuvant Topical Oxygen Therapy (Topox) Versus Conventional Methods in The Management of Non-Healing Infected Wounds. 2010. http://applications.emro.who.int/imemrf/Ann_Punjab_Med_Coll/Ann_Punjab_Med_Coll_2010_4_2_95_100.pdf. Accessed May 3, 2017.
Nie K, Li P, Zeng X, et al. Clinical observation of basic fibroblast growth factor combined with topical oxygen therapy in enhancing burn wound healing. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010;24(6):643-646.
Niederauer MQ, Michalek JE, Armstrong DG. Interim results for a prospective, randomized, double-blind multicenter study comparing continuous diffusion of oxygen therapy to standard moist wound therapy in the treatment of diabetic foot ulcers. Wound Medicine. 2015;8:19-23. doi:10.1016/j.wndm.2015.03.005
Niederauer MQ, Michalek JE, Armstrong DG. A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen Therapy to Sham Therapy in the Treatment of Diabetic Foot Ulcers. Journal of Diabetes Science and Technology. 2017;11(5):883-891. doi:10.1177/1932296817695574
Patel C. Topical Oxygen Therapy as an Adjunct in Complex Wound Care. unpublished. 2009.
Quan SY, Lazarus GS, Kohli AR, Kapoor R, Margolis DJ. Digital Imaging of Wounds: Are Measurements Reproducible Among Observers? The International Journal of Lower Extremity Wounds. 2007;6(4):245-248. doi:10.1177/1534734607306880
Tawfick W, Sultan S. Does Topical Wound Oxygen (TWO2) Offer an Improved Outcome Over Conventional Compression Dressings (CCD) in the Management of Refractory Venous Ulcers (RVU)? A Parallel Observational Comparative Study. European Journal of Vascular and Endovascular Surgery. 2009;38(1):125-132. doi:10.1016/j.ejvs.2009.03.027
Tawfick WA, Sultan S. Technical and clinical outcome of topical wound oxygen in comparison to conventional compression dressings in the management of refractory nonhealing venous ulcers. Vasc Endovascular Surg. 2013;47(1):30-37. doi:10.1177/1538574412467684
Winfeld B. Topical Oxygen and Hyperbaric Oxygen Therapy Use and Healing Rates in Diabetic Foot Ulcers. Wounds: a compendium of clinical research and practice. 2014;26:E39-E47.
Woo KY, Coutts PM, Sibbald RG. Continuous topical oxygen for the treatment of chronic wounds: a pilot study. Advances in skin & wound care. 2012;25(12):543–547.
Yu J, Lu S, McLaren A-M, Perry JA, Cross KM. Topical oxygen therapy results in complete wound healing in diabetic foot ulcers: Natrox heals diabetic foot ulcers. Wound Repair and Regeneration. 2016;24(6):1066-1072. doi:10.1111/wrr.12490

Public Health

MacKenzie EJ. Health-Care Costs Associated with Amputation or Reconstruction of a Limb-Threatening Injury. The Journal of Bone and Joint Surgery (American). 2007;89(8):1685. doi:10.2106/JBJS.F.01350
Margolis DJ, Malay DS, Hoffstad OJ, et al. Economic burden of diabetic foot ulcers and amputations. 2011. https://www.ncbi.nlm.nih.gov/books/NBK65152. Accessed August 28, 2017.
Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair and Regeneration. 2009;17(6):763-771. doi:10.1111/j.1524-475X.2009.00543.x

Review Articles

Brimson CH, Nigam Y. The role of oxygen-associated therapies for the healing of chronic wounds, particularly in patients with diabetes: Oxygen-associated therapies for the healing of wounds. Journal of the European Academy of Dermatology and Venereology. 2013;27(4):411-418. doi:10.1111/j.1468-3083.2012.04650.x
Dissemond J, Kröger K, Storck M, Risse A, Engels P. Topical oxygen wound therapies for chronic wounds: a review. Journal of Wound Care. 2015;24(2):53-63. doi:10.12968/jowc.2015.24.2.53
Eisenbud DE. Oxygen in Wound Healing. Clinics in Plastic Surgery. 2012;39(3):293-310. doi:10.1016/j.cps.2012.05.001
Gordillo GM, Sen CK. Evidence-Based Recommendations for the Use of Topical Oxygen Therapy in the Treatment of Lower Extremity Wounds. The International Journal of Lower Extremity Wounds. 2009;8(2):105-111. doi:10.1177/1534734609335149
Gotrupp F, Dissemond J, Baines C, Frykberg R, Jensen PO, Kot J, Kroger K,Longobardi P. Use of Oxygen Therapies in Wound Healing - Focus on Topical and Hyperbaric Oxygen Treatment. Journal of Wound Care 2017;26:S2-S42.
Guo S, DiPietro LA. Factors Affecting Wound Healing. Journal of Dental Research. 2010;89(3):219-229. doi:10.1177/0022034509359125
Howard MA, Asmis R, Evans KK, Mustoe TA. Oxygen and wound care: A review of current therapeutic modalities and future direction: Oxygen therapeutic modality review. Wound Repair and Regeneration. 2013;21(4):503-511. doi:10.1111/wrr.12069
Ladizinsky D, Roe D. New insights into oxygen therapy for wound healing. Wounds. 2010;22(12):294-300.
Mutluoglu M, Cakkalkurt A, Uzun G, Aktas S. Topical Oxygen for Chronic Wounds: A PRO/CON Debate. Journal of the American College of Clinical Wound Specialists. 2013;5(3):61-65. doi:10.1016/j.jccw.2014.12.003
Orsted HL, Poulson R, Baum J, et al. Evidence-based practice standards for the use of topical pressurised oxygen therapy. International wound journal. 2012;9(3):271–284.
Singer AJ, Tassiopoulos A, Kirsner RS. Evaluation and Management of Lower-Extremity Ulcers. Campion EW, ed. New England Journal of Medicine. 2017;377(16):1559-1567. doi:10.1056/NEJMra1615243

Publication History

Publication Date: October 4, 2018
Originally Published